Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal of ginseng research

In vitro iron nanoparticles modulate ginsenoside biosynthesis and trigger ROS-mediated stress response in ginseng adventitious roots.

  1. 1Department of Applied Plant Science, College of Agriculture and Life Science, Chonnam National University, Gwangju, 61186, Republic of Korea.
  2. 2Interdisciplinary Program in IT-Bio Convergence System, Chonnam National University, Gwangju, 61186, Republic of Korea.
  3. 3Laboratory of Plant Biotechnology, Institute of Biology, Mongolian Academy of Sciences, Ulaanbaatar, 13330, Mongolia.

Abstract

Background

Enhancing ginsenoside accumulation is essential for improving the medicinal quality of Panax ginseng. Although iron nanoparticles (Fe-NPs) have emerged as promising elicitors of secondary metabolism, their specific effects on ginsenoside biosynthesis remains elusive.Methods

Ginseng adventitious roots were treated with Fe-NP treatment in comparison with a conventional iron source (Fe₃O₄). Physiological responses, ginsenoside profiles, and the expression of key biosynthetic and reactive oxygen species (ROS)-related genes were analyzed to compare elicitation efficiency and potential toxicity.Results

At a lower concentration (10 ϻM), Fe-NP concentrations markedly induced key ginsenoside-biosynthetic genes and increased total ginsenoside content by 14-16%, whereas equivalent concentrations of Fe₃O₄ caused no significant metabolic changes, demonstrating the superior elicitation efficiency of the nanoparticle formulation. In contrast, higher Fe-NP doses (50-100 μM) caused iron toxicity and suppressed ginsenoside accumulation, likely through excessive ROS generation as supported by strong induction of ROS-detoxification genes. Notably, ginsenoside Re levels increased under iron stress, suggesting a potential antioxidative role.Conclusion

Overall, our findings reveal a dose-dependent dual effect of Fe-NPs, promoting ginsenoside biosynthesis at optimal doses while triggering ROS-mediated suppression at higher levels, and highlight the importance of precise Fe-NP dosage optimization for biotechnological applications.

Related

  1. Ginsenoside Rb1 alleviates uterine aging via AMPK-mediated mTOR inactivation
    Ping Zhou, Yue Wang, Ming Cheng +14
    Signal Transduction and Targeted TherapyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  2. Ginsenoside Rg1 Alleviates Chronic Obstructive Pulmonary Disease Partially Through Regulating ABCB1-Mediated Mitochondrial Dysfunction.
    Wenhui Xu, Jinghong Ye, Kezhou Dong +4
    Journal of biochemical and molecular toxicologyPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCPMC
  3. Ginsenoside Rg2 attenuates TGF-β1/Smad-mediated fibrotic remodeling in aged male mice with sarcopenia
    Yu Liu, Yuxin Zou, Honglin Chen +18
    Journal of Ginseng ResearchPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationDOAJEurope PMCPMC
  4. Chrysanthemum Morifolium-Derived Nanovesicles Reduce Lactate-Associated Histone Lactylation and Modulate Microglia-Mediated Neuroinflammation in Sepsis-Associated Encephalopathy.
    Kaiqiang Li, Xuling Luo, Xiaoting Zhang +9
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. PbSnRK1-Mediated Phosphorylation of PbTCP13 Regulates Glucose-Responsive Lignin Biosynthesis via PbMYB11 During Pear Stone Cell Formation.
    Jianan He, Xuxu Wang, Abdul Basit +12
    Plant biotechnology journalPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{bayaraa2026vitro,
  title = {{In vitro iron nanoparticles modulate ginsenoside biosynthesis and trigger ROS-mediated stress response in ginseng adventitious roots.}},
  author = {Unenzaya Bayaraa and Jin Hoon Jang and Sudheeran Pradeep Kumar and Ok Ran Lee},
  journal = {Journal of ginseng research},
  year = {2026},
  month = aug,
  doi = {10.1016/j.jgr.2026.101118},
  url = {https://europepmc.org/article/MED/42948593},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - In vitro iron nanoparticles modulate ginsenoside biosynthesis and trigger ROS-mediated stress response in ginseng adventitious roots.
AU  - Unenzaya Bayaraa
AU  - Jin Hoon Jang
AU  - Sudheeran Pradeep Kumar
AU  - Ok Ran Lee
PY  - 2026
DA  - 2026/08/06
JO  - Journal of ginseng research
DO  - 10.1016/j.jgr.2026.101118
UR  - https://europepmc.org/article/MED/42948593
AB  - Background  Enhancing ginsenoside accumulation is essential for improving the medicinal quality of Panax ginseng. Although iron nanoparticles (Fe-NPs) have emerged as promising elicitors of secondary metabolism, their specific effects on ginsenoside biosynthesis remains elusive.Methods  Ginseng adventitious roots were treated with Fe-NP treatment in comparison with a conventional iron source (Fe₃O₄). Physiological responses, ginsenoside profiles, and the expression of key biosynthetic and reactive oxygen species (ROS)-related genes were analyzed to compare elicitation efficiency and potential toxicity.Results  At a lower concentration (10 ϻM), Fe-NP concentrations markedly induced key ginsenoside-biosynthetic genes and increased total ginsenoside content by 14-16%, whereas equivalent concentrations of Fe₃O₄ caused no significant metabolic changes, demonstrating the superior elicitation efficiency of the nanoparticle formulation. In contrast, higher Fe-NP doses (50-100 μM) caused iron toxicity and suppressed ginsenoside accumulation, likely through excessive ROS generation as supported by strong induction of ROS-detoxification genes. Notably, ginsenoside Re levels increased under iron stress, suggesting a potential antioxidative role.Conclusion  Overall, our findings reveal a dose-dependent dual effect of Fe-NPs, promoting ginsenoside biosynthesis at optimal doses while triggering ROS-mediated suppression at higher levels, and highlight the importance of precise Fe-NP dosage optimization for biotechnological applications.
SN  - 1226-8453
SN  - 2093-4947
ER  -